The small number of patients precluded statistical correlation with response, but two of the four patients with a decrease of HIF-1α expression experienced a decrease in tumor size (19% and 15% decrease in prostate and fallopian tube cancers, respectively). This evidence concerns the gene HIF1A and fallopian tube cancer.